By expenditures
| Name | Title | Type |
|---|---|---|
| Susan Cancro | EXECUTIVE DIRECTOR | Auditee |
| Kyle Schafer, Cpa | Shareholder | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 338820 | 2023 | 2025-01-20 | Maner Costerisan | $2.50M |
| 294042 | 2022 | 2024-03-07 | Maner Costerisan | $11.09M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 338820 | 2023 | 2025-01-20 | 1096162 | 2023-002 | Significant Deficiency | Yes | N |
| 338820 | 2023 | 2025-01-20 | 1096161 | 2023-002 | Significant Deficiency | Yes | N |
| 338820 | 2023 | 2025-01-20 | 1096160 | 2023-002 | Significant Deficiency | Yes | N |
| 338820 | 2023 | 2025-01-20 | 1096159 | 2023-002 | Significant Deficiency | Yes | N |
| 338820 | 2023 | 2025-01-20 | 1096158 | 2023-002 | Significant Deficiency | Yes | N |
| 338820 | 2023 | 2025-01-20 | 1096157 | 2023-002 | Significant Deficiency | Yes | N |
| 338820 | 2023 | 2025-01-20 | 1096156 | 2023-002 | Significant Deficiency | Yes | N |
| 338820 | 2023 | 2025-01-20 | 519720 | 2023-002 | Significant Deficiency | Yes | N |
| 338820 | 2023 | 2025-01-20 | 519719 | 2023-002 | Significant Deficiency | Yes | N |
| 338820 | 2023 | 2025-01-20 | 519718 | 2023-002 | Significant Deficiency | Yes | N |
| 338820 | 2023 | 2025-01-20 | 519717 | 2023-002 | Significant Deficiency | Yes | N |
| 338820 | 2023 | 2025-01-20 | 519716 | 2023-002 | Significant Deficiency | Yes | N |
| 338820 | 2023 | 2025-01-20 | 519715 | 2023-002 | Significant Deficiency | Yes | N |
| 338820 | 2023 | 2025-01-20 | 519714 | 2023-002 | Significant Deficiency | Yes | N |
| 294042 | 2022 | 2024-03-07 | 950850 | 2022-002 | Significant Deficiency | - | N |
| 294042 | 2022 | 2024-03-07 | 374408 | 2022-002 | Significant Deficiency | - | N |